Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices

Information

  • Patent Grant
  • 10004510
  • Patent Number
    10,004,510
  • Date Filed
    Friday, June 1, 2012
    12 years ago
  • Date Issued
    Tuesday, June 26, 2018
    6 years ago
Abstract
The present technology relates to systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices. In some embodiments, the systems include a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm and a supplemental stabilizer connected to the closure structure. The supplemental stabilizer can be configured to reside in a parent artery and press outward against a luminal wall thereof. The systems can further include a shock absorbing structure coupled to a proximal end portion of the closure structure and to a distal end portion of the supplemental stabilizer. The shock absorbing structure can inhibit movement or dislodgement of the closure structure or the supplemental stabilizer relative to the aneurysm.
Description
TECHNICAL FIELD

The present technology relates to implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. For example, selected embodiments of the present technology comprise shock absorbing structures that can inhibit dislodgement of the device relative to the aneurysm.


BACKGROUND

Many of the currently available surgical approaches for closing openings and repairing defects in anatomical lumens and tissues (e.g., blood vessels), septal defects, and other types of anatomical irregularities and defects are highly invasive. Surgical methods for clipping brain aneurysms, for example, require opening the skull, cutting or removing overlying brain tissue, clipping and repairing the aneurysm from outside the blood vessel, and then reassembling tissue and closing the skull. The risks related to anesthesia, bleeding, and infection associated with these types of procedures are high, and tissue that is affected during the procedure may or may not survive and continue functioning.


Minimally invasive techniques for treating aneurysms are accordingly highly desirable. In general, such minimally invasive therapeutic techniques help prevent material that collects or forms in the aneurysm cavity from entering the bloodstream and help prevent blood from entering and collecting in the aneurysm. This is often accomplished by introducing various materials and devices into the aneurysm. For example, implantable vaso-occlusive metallic structures are well known and commonly used. Many conventional vaso-occlusive devices have helical coils constructed from a shape memory material or noble metal that forms a desired coil configuration upon exiting the distal end of a delivery catheter. The function of the coil is to fill the space formed by an anatomical defect and to facilitate the formation of an embolus with the associated allied tissue. Multiple coils of the same or different structures may be implanted serially in a single aneurysm or other vessel defect during a procedure. Implantable framework structures are also used in an attempt to stabilize the wall of the aneurysm or defect prior to insertion of filling material such as coils. It is important to accurately implant vaso-occlusive devices within the internal volume of a cavity and to maintain the devices within the internal volume of the aneurysm. Migration or projection of a vaso-occlusive device from the cavity may interfere with blood flow or nearby physiological structures and can pose a serious health risk.


In addition to the difficulties of delivering implantable occlusion devices, some types of aneurysms are challenging to treat because of the particularities of the treatment site and/or the structural features of the aneurysm itself. Wide-neck aneurysms, for example, are known to present particular difficulty in the placement and retention of vaso-occlusive coils. Aneurysms at sites of vascular bifurcation are another example where the anatomical structure poses challenges to methods and devices that are effective in treating the typical sidewall aneurysms. It is therefore challenging to position conventional implantable devices during deployment, prevent shifting or migration of such devices after deployment, and preserve blood flow in neighboring vessels following deployment.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A-1C are views of an aneurysm device having a shock absorbing structure configured in accordance with an embodiment of the technology.



FIG. 2 is a partially schematic illustration of the shock absorbing structure of FIG. 1.



FIG. 3 is a view of an aneurysm device having a shock absorbing structure configured in accordance with an additional embodiment of the technology.



FIG. 4 is a view of an aneurysm device having a shock absorbing structure configured in accordance with an additional embodiment of the technology.





DETAILED DESCRIPTION

The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology comprise shock absorbing structures that can inhibit dislodgement of the device relative to the aneurysm. The following description provides many specific details for a thorough understanding of, and enabling description for, embodiments of the disclosure. Well-known structures, systems, and methods often associated with such systems have not been shown or described in detail to avoid unnecessarily obscuring the description of the various embodiments of the disclosure. In addition, those of ordinary skill in the relevant art will understand that additional embodiments may be practiced without several of the details described below.



FIGS. 1A-1C are views of an aneurysm device 150 having a shock absorbing structure configured in accordance with an embodiment of the technology. In particular, FIG. 1A is an isometric view of the aneurysm device 150 and FIG. 1B is a front view of the device 150 outside of a patient, and FIG. 1C is a partially schematic view of the device 150 at a treatment site proximate to an aneurysm A in a patient. Referring to FIGS. 1A-1C together, the aneurysm device 150 comprises a closure structure 152, one or more shock absorbing structures 101 (two are shown in the illustrated embodiment), and a supplemental stabilizer or support 153 extending from the closure structure 152 and the shock absorbing structures 101.


The closure structure 152 can be a frame, scaffold, or other structure that at least partially occludes the neck N of the aneurysm A to prevent embolic coils (shown in FIG. 1C) or other coagulative material within the aneurysm A from escaping into the bloodstream. The proximally-extending sides of the closure structure 152 and the supplemental stabilizer 153 hold the curved portion of the closure structure 152 at the neck N of the aneurysm A. The closure structure 152 includes a perimeter support 160 and an inner support 170. The supports 160 and 170 can have a rhombus-like (e.g., diamond-shaped) shape or configuration. The perimeter support 160 and inner support 170 can be joined at junctions 162 and 164. The aneurysm device 150 can also have struts 180a-d projecting proximally from the junctions 162 and 164. Struts 180a-b are connected at junction 162 and struts 180c-d are connected at junction 164 to form the supplemental stabilizer 153 with proximal anchoring segments.


In multiple device embodiments, the aneurysm device 150 may be deployed such that it is anchored along a specific portion of the neck N of the aneurysm A. As shown in FIG. 1C, for example, the closure portion 152 of the aneurysm device 150 can bridge a portion or all of the neck N and control blood flow into the aneurysm A. The supports 160 and 170 can lodge in side branch vessels SB 1 and SB2, while struts 180a-d can press against a wall of a parent vessel PV to collectively secure placement of the aneurysm device 150. As will be discussed in further detail below with reference to FIG. 2, the shock absorbing structures 101 can smooth out or dampen movement of the aneurysm device 150 relative to the blood vessel walls. Additionally, the shock absorbing structures 101 can enhance the junction of the closure structure 152 to the supplemental stabilizer 153 and can improve the aneurysm device's ability to withstand motion relative to the blood vessel walls.



FIG. 2 is a partially schematic illustration of the shock absorbing structure 101. The shock absorbing structure 101 includes a shock absorbing assembly 220 distally coupled to the junction 162 between the closure structure 152 and the supplemental stabilizer 153. In the illustrated embodiment, the shock absorbing assembly 220 comprises a leaf-spring having a first spring arm 226a and a second spring arm 226b extending laterally from the junction 162. The first and second spring arms 226a and 226b can surround an aperture 224. In further embodiments, the shock absorbing assembly 220 can include other types of springs or other shock-absorbing mechanisms. The supplemental stabilizer 153 can move proximally, distally, and/or laterally relative to the closure structure 152 as the shock absorbing assembly 220 contracts and expands.


A proximally-extending portion 232 of the closure structure 152 may be coupled to a distally-extending portion 222 of the shock absorbing structure 101 by an attachment feature 230. In some embodiments, the attachment feature 230 comprises a solder attachment. In further embodiments, however, other attachment mechanisms can be used. The flexibility provided by the shock-absorbing assembly 220 and the attachment feature 230 is expected to inhibit movement of the supplemental stabilizer 153 relative to a vessel wall and help prevent movement in the blood vessel from dislodging the aneurysm device 150 after deployment.



FIG. 2 further illustrates additional details of the shock absorbing structure. The first spring arm 226a can include a first spring arm proximal 221a end and a first spring arm distal end 223a while the second spring art 226b can include a second spring arm proximal end 221b and a second spring arm distal end 223b. The first and the second spring arm proximal ends 221a, 221b can couple to and extend away from the junction 162 at an angle to each other. The first and the second spring arms 226a, 226b can form and at least partially surround the aperture 224. The first and the second spring arm distal ends 223a, 223b meet at the distally-extending portion 222 of the shock absorbing structure 101 to form a generally V-shaped arrangement. The distally-extending portion 222 is proximate to a notch 225 in the generally V-shaped arrangement.



FIGS. 3 and 4 illustrate aneurysm devices having shock absorbing structures configured in accordance with additional embodiments of the technology. The aneurysm devices shown in FIGS. 3 and 4 include several features generally similar to the aneurysm device 150 described above with reference to FIG. 1. Referring to FIG. 3, for example, an aneurysm device 300 includes a closure structure 302 having a perimeter support 310 and an inner support 320. The shock absorbing structure 101 is located at a proximal end of the closure structure 302. The aneurysm device 300 further includes a supplemental stabilizer or support 303 extending from the shock absorbing structure 101. The shock absorbing structure 101 can enhance the junction of the closure structure 302 to the supplemental stabilizer 303 and can improve the aneurysm device's ability to withstand motion within the blood vessel.


Referring now to FIG. 4, an aneurysm device 400 includes a closure structure 402 including a plurality of struts that form a perimeter support 410 and an inner support 420. The aneurysm device 400 includes shock absorbing structures 101 positioned on a proximal end of the closure structure 402 and coupled to a distal end of a supplemental stabilizer 403. The aneurysm device 400 further includes a barrier 440 that covers at least a portion of the perimeter support 410. In the particular embodiment illustrated in FIG. 4, the barrier 440 can be a membrane or other type of cover that extends across the full lateral aspect of the perimeter support 410 and a significant portion of the U-shaped curved region of both the perimeter support 410 and the inner support 420. The barrier 440 can enhance the separation between the cavity of an aneurysm and the lumen of the side branch vessels compared to aneurysm devices without the barrier.


EXAMPLES
Example 1

An aneurysm device endovascularly deliverable to a site proximate to an aneurysm near a parent artery with bifurcating downstream branches, the aneurysm device comprising:


a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm;


a supplemental stabilizer connected to the closure structure, the supplemental stabilizer configured to reside in the parent artery and press outward against a luminal wall thereof; and


a shock absorbing structure coupled to a proximal end portion of the closure structure and to a distal end portion of the supplemental stabilizer.


Example 2

The aneurysm device of example 1 wherein the shock absorbing structure comprises a spring.


Example 3

The aneurysm device of example 2 wherein the spring comprises a leaf spring having a first spring arm and a second spring arm, and wherein the first and second spring aims at least partially surround an aperture.


Example 4

The aneurysm device of example 3 wherein the first spring arm and the second spring aim extend laterally from at least one of the closure structure or the supplemental stabilizer.


Example 5

The aneurysm device of example 2 wherein the supplemental stabilizer is configured to move proximally, distally, and/or laterally relative to the closure structure as the shock absorbing assembly exhibits spring movement.


Example 6

The aneurysm device of example 1, further comprising an attachment feature configured to couple the closure structure to the shock absorbing structure.


Example 7

The aneurysm device of example 6 wherein the attachment feature comprises hardened solder.


Example 8

The aneurysm device of example 1 wherein the shock absorbing structure comprises a moveable junction between the closure structure and the supplemental stabilizer.


Example 9

A system for treating an aneurysm, the system comprising:


a distal framework portion comprising a distal-facing aspect configured to enclose the aneurysm;


a proximal support framework connected to the distal framework portion, the support framework configured to reside in a parent artery and biased to press outward against a luminal wall thereof; and


a spring coupled to the distal framework portion and proximally movable relative to the distal framework portion.


Example 10

The system of example 9 wherein the spring comprises a junction connecting the distal framework portion and the proximal support framework.


Example 11

The system of example 9 wherein the spring comprises a leaf spring.


Example 12

The system of example 9 wherein the distal framework portion comprises a set of distal struts forming at least one quadrilateral form with first and second longitudinal junctions, and wherein the system further comprises a barrier covering at least a portion of the distal struts.


Example 13

The system of example 9 wherein the barrier comprises a membrane configured to enhance a separation between a cavity of the aneurysm and the parent artery.


Example 14

A method of treating an aneurysm located at a site within a blood vessel, the method comprising:


positioning a framework comprising a distal portion and a proximal portion at a site proximate to the aneurysm;


applying a force outward from the proximal portion of the framework against a luminal wall of the blood vessel, and


absorbing movement of the framework relative to the blood vessel with a shock absorbing structure operably coupled with the framework.


Example 15

The method of example 14 wherein absorbing movement of the framework comprises dampening movement of the framework relative to a blood vessel wall with the shock-absorbing structure.


Example 16

The method of example 14 wherein absorbing movement of the framework comprises absorbing movement with a spring connecting the distal portion and the proximal portion.


Example 17

The method of example 14 wherein absorbing movement of the framework comprises inhibiting dislodgement of the framework relative to the aneurysm.


Example 18

The method of example 14 wherein absorbing movement of the framework comprises absorbing movement with a leaf spring.


Example 19

The method of example 14 wherein absorbing movement of the framework comprises absorbing movement of the distal portion relative to the proximal portion.


Example 20

The method of example 14, further comprising at least partially occluding the aneurysm with a barrier membrane coupled to the distal portion.


The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments. In particular, the clot removal devices described above with reference to particular embodiments can include one or more additional features or components, or one or more of the features described above can be omitted.


From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.


Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, B all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.

Claims
  • 1. An aneurysm device endovascularly deliverable to a site proximate to an aneurysm near a parent artery with bifurcating downstream branches, the aneurysm device comprising: a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm;a supplemental stabilizer connected to the closure structure, the supplemental stabilizer configured to reside in the parent artery and press outward against a luminal wall thereof;a junction between the closure structure and the supplemental stabilizer; anda shock absorbing structure coupled to a proximal end portion of the closure structure and to a distal end portion of the supplemental stabilizer, comprising: a first spring arm comprising a first spring arm proximal end and a first spring arm distal end; anda second spring arm comprising a second spring arm proximal end and a second spring arm distal end;wherein the first and second spring arm proximal ends are coupled to each other at the junction,wherein the first spring arm and the second spring arm extend away from the junction at an angle to each other,wherein the first and the second spring arms at least partially surround an aperture,wherein the first and the second spring arms act as a leaf spring,wherein the first and the second spring arm distal ends meet at a distally-extending portion of the shock absorbing structure to form a generally V-shaped arrangement and the distally-extending portion is proximate to a notch in the generally V-shaped arrangement, andwherein the proximal end portion of the closure structure coupled to the distally-extending portion of the shock absorbing structure.
  • 2. The aneurysm device of claim 1 wherein the supplemental stabilizer is configured to move proximally, distally, and/or laterally relative to the closure structure as the shock absorbing assembly exhibits spring movement.
  • 3. The aneurysm device of claim 1, further comprising an attachment feature configured to couple the closure structure to the shock absorbing structure.
  • 4. The aneurysm device of claim 3 wherein the attachment feature comprises hardened solder.
  • 5. A system for treating an aneurysm, the system comprising: a distal framework portion comprising a distal-facing aspect configured to enclose the aneurysm;a proximal support framework connected to the distal framework portion, the support framework configured to reside in a parent artery and biased to press outward against a luminal wall thereof; anda spring coupled to the distal framework portion and proximally movable relative to the distal framework portion, wherein the spring comprises: a first spring arm comprising a first spring arm proximal end and a first spring arm distal end;a second spring arm comprising a second spring arm proximal end and a second spring arm distal end; anda junction between the distal framework portion and the proximal support framework,wherein the first spring arm and the second spring arm extend away from the junction and toward the distal framework portion such that the first spring arm and the second spring arm have a generally V-shaped arrangement formed from the first and the second spring arm proximal ends meeting at the junction and the first and the second spring arm distal ends meeting at the distal framework portion, andwherein a proximal portion of the distal framework portion resides proximate to a notch in the generally V-shaped arrangement between the first and second spring arms.
  • 6. The system of claim 5 wherein the junction connects the distal framework portion and the proximal support framework.
  • 7. The system of claim 5 wherein the distal framework portion comprises a set of distal struts forming at least one quadrilateral form with first and second longitudinal junctions, and wherein the system further comprises a barrier covering at least a portion of the distal struts.
  • 8. The system of claim 7 wherein the barrier comprises a membrane configured to enhance a separation between a cavity of the aneurysm and the parent artery.
  • 9. A method of treating an aneurysm located at a site within a blood vessel, the method comprising: positioning a framework comprising a distal portion and a proximal portion at a site proximate to the aneurysm;applying a force outward from the proximal portion of the framework against a luminal wall of the blood vessel;absorbing movement of the framework relative to the blood vessel with a generally V-shaped spring connecting the distal portion and the proximal portion of the framework; anddisposing a section of the distal portion within a notch in the generally V-shaped spring,wherein the generally V-shaped spring comprises a first spring arm and a second spring arm; wherein the first spring arm comprises a first spring arm proximal end and a first spring arm distal end; wherein the second spring arm comprises a second spring arm proximal end and a second spring arm distal end,wherein the first and the second spring arm proximal ends are coupled at a junction; wherein the first spring arm and second spring arm extend away from the junction at an angle to each other,wherein the first and the second spring arms at least partially surround an aperture,wherein the first and the second spring arms act as a leaf spring, andwherein the first and the second spring arm distal ends meet at a distally-extending portion to form a generally V-shaped arrangement and the distally-extending portion is proximate to a notch in the generally V-shaped arrangement.
  • 10. The method of claim 9 wherein absorbing movement of the framework comprises inhibiting dislodgement of the framework relative to the aneurysm.
  • 11. The method of claim 9 wherein absorbing movement of the framework comprises absorbing movement with the leaf spring.
  • 12. The method of claim 9, further comprising at least partially occluding the aneurysm with a barrier membrane coupled to the distal portion.
CROSS-REFERENCE TO RELATED APPLICATION

The present application is a U.S. National Stage of International Application No. PCT/US2012/040552, filed Jun. 1, 2012, entitled “SYSTEMS AND METHODS FOR ENCLOSING AN ANATOMICAL OPENING, INCLUDING SHOCK ABSORBING ANEURYSM DEVICES,” and claims the benefit of U.S. Provisional Patent Application No. 61/493,348, filed Jun. 3, 2011, both of which are incorporated herein by reference in their entirety.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/US2012/040552 6/1/2012 WO 00 4/30/2014
Publishing Document Publishing Date Country Kind
WO2012/167150 12/6/2012 WO A
US Referenced Citations (297)
Number Name Date Kind
3868956 Alfidi et al. Mar 1975 A
4164045 Bokros et al. Aug 1979 A
4248234 Assenza et al. Feb 1981 A
4645495 Vaillancourt Feb 1987 A
4651751 Swendson et al. Mar 1987 A
4665906 Jervis May 1987 A
4706671 Weinrib Nov 1987 A
4710192 Liotta et al. Dec 1987 A
4739768 Engelson Apr 1988 A
4820298 Leveen et al. Apr 1989 A
4873978 Ginsburg Oct 1989 A
4909787 Danforth Mar 1990 A
4994069 Ritchart et al. Feb 1991 A
5011488 Ginsburg Apr 1991 A
5074869 Daicoff Dec 1991 A
5122136 Guglielmi et al. Jun 1992 A
5226911 Chee et al. Jul 1993 A
5250071 Palermo Oct 1993 A
5261916 Engelson Nov 1993 A
5263964 Purdy Nov 1993 A
5263974 Matsutani et al. Nov 1993 A
5271414 Partika et al. Dec 1993 A
5304195 Twyford, Jr. et al. Apr 1994 A
5334168 Hemmer Aug 1994 A
5342386 Trotta Aug 1994 A
5350397 Palermo et al. Sep 1994 A
5354295 Guglielmi et al. Oct 1994 A
5527338 Purdy Jun 1996 A
5531685 Hemmer et al. Jul 1996 A
5578074 Mirigian Nov 1996 A
5624449 Pham et al. Apr 1997 A
5643254 Scheldrup et al. Jul 1997 A
5665106 Hammerslag Sep 1997 A
5669931 Kupiecki et al. Sep 1997 A
5693067 Purdy Dec 1997 A
5733294 Forber et al. Mar 1998 A
5733329 Wallace et al. Mar 1998 A
5749890 Shaknovich May 1998 A
5749894 Engelson May 1998 A
5759194 Hammerslag Jun 1998 A
5766192 Zacca Jun 1998 A
5769884 Solovay Jun 1998 A
5797953 Tekulve Aug 1998 A
5814062 Sepetka et al. Sep 1998 A
5843103 Wulfman Dec 1998 A
D407818 Mariant et al. Apr 1999 S
5895391 Farnholtz Apr 1999 A
5895410 Forber et al. Apr 1999 A
5910145 Fischell et al. Jun 1999 A
5911737 Lee et al. Jun 1999 A
5916235 Guglielmi Jun 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5925683 Park Jul 1999 A
5928260 Chin et al. Jul 1999 A
5933329 Tijanoc et al. Aug 1999 A
5935114 Jang et al. Aug 1999 A
5935148 Villar et al. Aug 1999 A
5951599 McCrory Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5980514 Kupiecki et al. Nov 1999 A
5980554 Lenker et al. Nov 1999 A
5984944 Forber Nov 1999 A
6007544 Kim Dec 1999 A
6013055 Bampos et al. Jan 2000 A
6022341 Lentz Feb 2000 A
6036720 Abrams et al. Mar 2000 A
6063070 Eder May 2000 A
6063104 Villar et al. May 2000 A
6071263 Kirkman Jun 2000 A
6077291 Das Jun 2000 A
6081263 LeGall et al. Jun 2000 A
6090125 Horton Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096021 Helm et al. Aug 2000 A
6096034 Kupiecki et al. Aug 2000 A
6102917 Maitland et al. Aug 2000 A
6110191 Dehdashtian et al. Aug 2000 A
6117157 Tekulve Sep 2000 A
6139564 Teoh Oct 2000 A
6146339 Biagtan et al. Nov 2000 A
6152944 Holman et al. Nov 2000 A
6168615 Ken et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6174322 Schneidt Jan 2001 B1
6183495 Lenker et al. Feb 2001 B1
6193708 Ken et al. Feb 2001 B1
RE37117 Palermo Mar 2001 E
6221066 Ferrera et al. Apr 2001 B1
6221086 Forber Apr 2001 B1
6224610 Ferrera May 2001 B1
6228052 Pohndorf May 2001 B1
6261305 Marotta et al. Jul 2001 B1
6293960 Ken Sep 2001 B1
6296622 Kurz et al. Oct 2001 B1
6309367 Boock Oct 2001 B1
6325807 Que Dec 2001 B1
6344041 Kupiecki et al. Feb 2002 B1
6344048 Chin et al. Feb 2002 B1
6361558 Hieshima et al. Mar 2002 B1
6375668 Gifford et al. Apr 2002 B1
6383174 Eder May 2002 B1
6398791 Que et al. Jun 2002 B1
6478773 Gandhi et al. Nov 2002 B1
6491711 Durcan Dec 2002 B1
6517515 Eidenschink Feb 2003 B1
6530935 Wensel et al. Mar 2003 B2
6533905 Johnson et al. Mar 2003 B2
6554794 Mueller et al. Apr 2003 B1
6589256 Forber Jul 2003 B2
6592605 Lenker et al. Jul 2003 B2
6613074 Mitelberg Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6626889 Simpson et al. Sep 2003 B1
6626928 Raymond et al. Sep 2003 B1
6638268 Niazi Oct 2003 B2
6652556 VanTassel et al. Nov 2003 B1
6663607 Slaikeu et al. Dec 2003 B2
6663648 Trotta Dec 2003 B1
6669795 Johnson et al. Dec 2003 B2
6672338 Esashi et al. Jan 2004 B1
6679836 Couvillon, Jr. Jan 2004 B2
6679903 Kurz Jan 2004 B2
6689141 Ferrera et al. Feb 2004 B2
6694979 Deem et al. Feb 2004 B2
6723112 Ho et al. Apr 2004 B2
6740073 Saville May 2004 B1
6740277 Howell et al. May 2004 B2
6746468 Sepetka et al. Jun 2004 B1
6780196 Chin et al. Aug 2004 B2
6790218 Jayaraman Sep 2004 B2
6802851 Jones et al. Oct 2004 B2
6811560 Jones et al. Nov 2004 B2
6824553 Samson et al. Nov 2004 B1
6835185 Ramzipoor et al. Dec 2004 B2
6837870 Duchamp Jan 2005 B2
6843802 Villalobos et al. Jan 2005 B1
6855153 Saadat Feb 2005 B2
6863678 Lee et al. Mar 2005 B2
6890218 Patwardhan et al. May 2005 B2
6911037 Gainor et al. Jun 2005 B2
6936055 Ken et al. Aug 2005 B1
6939055 Durrant et al. Sep 2005 B2
6986774 Middleman et al. Jan 2006 B2
6994092 van der Burg et al. Feb 2006 B2
7011094 Rapacki et al. Mar 2006 B2
7033374 Schaefer et al. Apr 2006 B2
7033387 Zadno-Azizi et al. Apr 2006 B2
7122043 Greenhalgh et al. Oct 2006 B2
7147659 Jones Dec 2006 B2
7156871 Jones et al. Jan 2007 B2
7169177 Obara Jan 2007 B2
7229461 Chin et al. Jun 2007 B2
7232461 Ramer Jun 2007 B2
7267679 McGuckin, Jr. et al. Sep 2007 B2
7306622 Jones et al. Dec 2007 B2
7322960 Yamamoto et al. Jan 2008 B2
7343856 Blohdorn Mar 2008 B2
7387629 Vanney et al. Jun 2008 B2
7410482 Murphy et al. Aug 2008 B2
7569066 Gerberding et al. Aug 2009 B2
7608088 Jones et al. Oct 2009 B2
7662168 McGuckin, Jr. et al. Feb 2010 B2
7857825 Moran et al. Dec 2010 B2
7892254 Klint et al. Feb 2011 B2
8016853 Griffen et al. Sep 2011 B2
8075585 Lee et al. Dec 2011 B2
8187315 Clauson et al. May 2012 B1
8262692 Rudakov Sep 2012 B2
8388650 Gerberding et al. Mar 2013 B2
8444667 Porter May 2013 B2
8470013 Duggal et al. Jun 2013 B2
8540763 Jones et al. Sep 2013 B2
8545530 Eskridge et al. Oct 2013 B2
8551132 Eskridge et al. Oct 2013 B2
8556953 Berez et al. Oct 2013 B2
8715312 Burke et al. May 2014 B2
8715338 Frid May 2014 B2
8728141 Riina et al. May 2014 B2
8747430 Porter Jun 2014 B2
8771341 Strauss et al. Jul 2014 B2
8915950 Cam et al. Dec 2014 B2
8926680 Ferrera et al. Jan 2015 B2
8956399 Cam et al. Feb 2015 B2
8979893 Gerberding et al. Mar 2015 B2
9060886 Molaei et al. Jun 2015 B2
9107670 Hannes et al. Aug 2015 B2
9119625 Bachman et al. Sep 2015 B2
9179918 Levy et al. Nov 2015 B2
9186267 Losordo et al. Nov 2015 B2
9192388 Cam et al. Nov 2015 B2
9211124 Campbell et al. Dec 2015 B2
9259229 Abrams et al. Feb 2016 B2
9277924 Clarke et al. Mar 2016 B2
20020026232 Marotta et al. Feb 2002 A1
20030033003 Harrison Feb 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030139802 Wulfman et al. Jul 2003 A1
20030181922 Alferness Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030195385 DeVore Oct 2003 A1
20030195553 Wallace et al. Oct 2003 A1
20030212412 Dillard et al. Nov 2003 A1
20040044391 Porter Mar 2004 A1
20040068314 Jones et al. Apr 2004 A1
20040087998 Lee et al. May 2004 A1
20040111112 Hoffmann Jun 2004 A1
20040158311 Berhow et al. Aug 2004 A1
20040167597 Constantino et al. Aug 2004 A1
20040167602 Fischell et al. Aug 2004 A1
20040172056 Guterman et al. Sep 2004 A1
20040193246 Ferrera Sep 2004 A1
20040210248 Gordon et al. Oct 2004 A1
20040210298 Rabkin et al. Oct 2004 A1
20050021023 Guglielmi et al. Jan 2005 A1
20050025797 Wang et al. Feb 2005 A1
20050033349 Jones Feb 2005 A1
20050033409 Burke Feb 2005 A1
20050096728 Ramer May 2005 A1
20050177224 Fogarty et al. Aug 2005 A1
20060004436 Amarant et al. Jan 2006 A1
20060030929 Musbach Feb 2006 A1
20060052862 Kanamaru et al. Mar 2006 A1
20060058837 Bose et al. Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060106418 Seibold et al. May 2006 A1
20060200234 Hines Sep 2006 A1
20060206199 Churchwell et al. Sep 2006 A1
20060247680 Amplatz et al. Nov 2006 A1
20060259131 Molaei et al. Nov 2006 A1
20060264905 Eskridge et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20070067015 Jones et al. Mar 2007 A1
20070088387 Eskridge et al. Apr 2007 A1
20070106311 Wallace et al. May 2007 A1
20070191884 Eskridge et al. Aug 2007 A1
20070198075 Levy Aug 2007 A1
20070203567 Levy Aug 2007 A1
20070270902 Slazas et al. Nov 2007 A1
20080004653 Sherman et al. Jan 2008 A1
20080004692 Henson et al. Jan 2008 A1
20080039930 Jones et al. Feb 2008 A1
20080147100 Wallace Jun 2008 A1
20080183143 Palisis et al. Jul 2008 A1
20080221600 Dieck et al. Sep 2008 A1
20080269774 Garcia et al. Oct 2008 A1
20080319533 Lehe Dec 2008 A1
20090069880 Vonderwalde et al. Mar 2009 A1
20090125053 Ferrera et al. May 2009 A1
20090306678 Hardert et al. Dec 2009 A1
20100023105 Levy et al. Jan 2010 A1
20100063531 Rudakov et al. Mar 2010 A1
20100094335 Gerberding et al. Apr 2010 A1
20110022149 Cox Jan 2011 A1
20110270373 Sampognaro et al. Nov 2011 A1
20120143237 Cam et al. Jun 2012 A1
20120143317 Cam et al. Jun 2012 A1
20120245674 Molaei et al. Sep 2012 A1
20120290067 Cam et al. Nov 2012 A1
20120296361 Cam et al. Nov 2012 A1
20130090682 Bachman et al. Apr 2013 A1
20130204290 Clarke et al. Aug 2013 A1
20130268046 Gerberding et al. Oct 2013 A1
20130268053 Molaei et al. Oct 2013 A1
20130274862 Cox et al. Oct 2013 A1
20130274863 Cox et al. Oct 2013 A1
20130274866 Cox et al. Oct 2013 A1
20130274868 Cox et al. Oct 2013 A1
20130304109 Abrams et al. Nov 2013 A1
20140052233 Cox et al. Feb 2014 A1
20140058420 Hannes et al. Feb 2014 A1
20140121752 Losordo et al. May 2014 A1
20140128901 Kang et al. May 2014 A1
20140142608 Eskridge et al. May 2014 A1
20140180377 Bose et al. Jun 2014 A1
20150039015 Gerberding Feb 2015 A1
20150142025 Brandeis May 2015 A1
20150142042 Cox May 2015 A1
20150142043 Furey May 2015 A1
20150157329 Rudakov et al. Jun 2015 A1
20150157331 Levy et al. Jun 2015 A1
20150164512 Chin et al. Jun 2015 A1
20150164665 Cam et al. Jun 2015 A1
20150182361 Ferrera et al. Jul 2015 A1
20150196305 Meyer et al. Jul 2015 A1
20150216534 Riina et al. Aug 2015 A1
20150216687 Gerberding et al. Aug 2015 A1
20150245932 Molaei et al. Sep 2015 A1
20150250628 Monstadt et al. Sep 2015 A1
20150282962 Strauss et al. Oct 2015 A1
20150327867 Bachman et al. Nov 2015 A1
20150342612 Wu et al. Dec 2015 A1
20160015395 Molaei et al. Jan 2016 A1
20160015396 Cox et al. Jan 2016 A1
20160030050 Franano et al. Feb 2016 A1
20160038153 Losordo et al. Feb 2016 A1
20160249936 Clarke et al. Sep 2016 A1
Foreign Referenced Citations (61)
Number Date Country
2006304660 Apr 2007 AU
1384726 Dec 2002 CN
1399530 Feb 2003 CN
1399531 Feb 2003 CN
101489492 Jul 2009 CN
102202585 Sep 2011 CN
102762156 Oct 2012 CN
103230290 Aug 2013 CN
103381101 Nov 2013 CN
103582460 Feb 2014 CN
10200802830 Apr 2009 DE
102008028308 Apr 2009 DE
0820726 Jan 1998 EP
1269935 Jan 2003 EP
1527753 May 2005 EP
2326259 Jun 2011 EP
2451363 May 2012 EP
2713904 Apr 2014 EP
1134421 Mar 2014 HK
2001286478 Oct 2001 JP
2002516705 Jun 2002 JP
2003512129 Apr 2003 JP
2005522266 Jul 2005 JP
2009512515 Mar 2009 JP
2013226419 Nov 2013 JP
20080081899 Sep 2008 KR
WO-9724978 Jul 1997 WO
WO-9726939 Jul 1997 WO
WO-9731672 Sep 1997 WO
WO-9823227 Jun 1998 WO
WO-9850102 Nov 1998 WO
WO-9905977 Feb 1999 WO
WO-9907294 Feb 1999 WO
WO-9915225 Apr 1999 WO
WO-0013593 Mar 2000 WO
WO-0130266 May 2001 WO
WO-2001093782 Dec 2001 WO
WO0200139 Jan 2002 WO
WO-2002000139 Jan 2002 WO
WO-0213899 Feb 2002 WO
WO-02071977 Sep 2002 WO
WO-02078777 Oct 2002 WO
WO-02087690 Nov 2002 WO
WO-03059176 Jul 2003 WO
WO-03075793 Sep 2003 WO
WO-04019790 Mar 2004 WO
WO-04026149 Apr 2004 WO
WO-04105599 Dec 2004 WO
WO-05033409 Apr 2005 WO
WO-05082279 Sep 2005 WO
WO-2006119422 Nov 2006 WO
WO-2007047851 Apr 2007 WO
WO-2008151204 Dec 2008 WO
WO-2010028314 Mar 2010 WO
WO-2011029063 Mar 2011 WO
WO-2012167137 Dec 2012 WO
WO-2012167156 Dec 2012 WO
WO-2013052920 Apr 2013 WO
WO-2013169380 Nov 2013 WO
WO-2014029835 Feb 2014 WO
WO-2015179377 Nov 2015 WO
Non-Patent Literature Citations (18)
Entry
Cordis NeuroVascular, Inc.; “Masstransit Microcatheter,” Product Prochure; No. 153-8383-3; Miami Lakes, FL, USA (2003).
Cordis NeuroVascular, Inc.; “Prolwer Select Plus Microcatheter,” Product Brochure; No. 154-9877-1; Miami Lakes, FL, USA (2003).
Cordis NeuroVascular, Inc.; “Prowler Select LP Microcatheter,” Product Brochure; No. 155-5585; Miami Lakes, FL, USA (2004).
Cordis NeuroVascular, Inc.; “Rapid Transit Microcatheter,” Product Brochure; No. 152-7369-2; Miami Lakes, FL, USA (2003).
Extended European Search Report, European Application No. 06826291.4, dated Nov. 19, 2009, 7 pages.
Gupta et al. SMST-2003: Proc. Intl. Conf. Shape Memory Superelastic Technol.; Pacific Grove, CA; p. 639; 2003.
International Search Report and Written Opinion for International Application PCT/US2013/031793, dated Jun. 26, 2013, 14 pages.
International Search Report and Written Opinion for Application No. PCT/US2010/047908, dated May 25, 2011.
International Search Report and Written Opinion for International Application No. PCT/US2009/056133, dated Oct. 26, 2009, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/US2010/047908, dated Mar. 15, 2012, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/US2012/040552, dated Aug. 28, 2012, 14 pages.
International Search Report and Written Opinion for International Application PCT/US2012/040536, dated Oct. 15, 2012, 17 pages.
International Search Report and Written Opinion for International Application PCT/US2012/040558, dated Oct. 8, 2012, 17 pages.
International Search Report and Written Opinion for International Application PCT/US2012/059133, dated Mar. 11, 2013, 15 pages.
International Search Report for International Application No. PCT/US06/40907, dated May 1, 2008, 2 pages.
Micrus Copr.; “Concourse 14 Microcatheter” Product Brochure; Sunnyvale ,CA, USA.
Polytetraflouroethylene Implants, DermNet NZ, Nov. 11, 2005, http://dermetnz.org/polytetrafluoroethylene.html.
Singapore Examination Report for Singapore Application No. 200802811-0, dated Jul. 12, 2009, 7 pages.
Related Publications (1)
Number Date Country
20140236216 A1 Aug 2014 US
Provisional Applications (1)
Number Date Country
61493348 Jun 2011 US